Jul 02, 2025
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $1.65 to $0.17.
The split itself did not change the total investment value.
Channel Therapeutics Corporation (CHRO) trades on the New York Stock Exchange Arca in the Biotechnology industry.
Channel Therapeutics Corporation company overviewThe latest split shown was on July 2, 2025. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
This history records one reverse split, on July 2, 2025.